Portfolio Entities
Portfolio Entities
About Us
About Us
Our People
Our People
Investment Strategy
Investment Strategy
Affiliates
Affiliates
Strategic Partners
Strategic Partners
Solution Partners
Solution Partners
Press Release
Press Release
Contact Us
Contact Us
Press Releases
Our Portfolio Milestones
Most recent updates from our portfolio entities
July,10 2024
Spine BioPharma, Inc. Announces Agreement with Ensol BioSciences, Inc. to Expand Indications for SB-01 For Injection
Read More
May,29 2024
MCRA Announces Record Success in Supporting Orthopedic Innovation
Read More
May,21 2024
Takeda and Inspire Researchers to Present Novel Study on Short Bowel Syndrome Patient Experience at DDW2024
Read More
April,8 2024
Exclusive: Synchron, a rival to Musk’s Neuralink, readies large-scale brain implant trial
Read More
March,11 2024
Implantable Brain-Computer Interface Collaborative Community (iBCI-CC) to Drive Innovation in Neurotechnology
Read More
February,28 2024
This ALS patient has a brain implant that translates his thoughts to computer commands
Read More
1
2
3
4
5
6
7
8
9
CONTACT US
We Welcome
Your Inquiries
Connect with our global team of experts.
505 Park Ave, New York,
NY 10022, USA
Nispetiye Cad. 39 Akat Apt. 11/3
Besiktas, Istanbul, Turkey
info@vbwatermarkholdings.com
Contact Form
Send